Evaluating medicines: let's use all the evidence
• The current drug regulatory system is outdated and relies primarily on a process of premarketing evaluation, followed by periodic reviews of reported adverse events. • While long-term medicine use for chronic conditions is now commonplace, current d
|Collections||ANU Research Publications|
|Source:||Medical Journal of Australia|
|01_Kelman_Evaluating_medicines:_let's_2007.pdf||233.71 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.